Additionally, BRCA2 mutations occur in 3.6–10% of all sporadic pancreatic cancers (Goggins et al., 1996; Ozcelik et al., 1997; Figer et al., 2001; Ferrone et al., 2009; Lucas et al., 2013; Luo et al., 2015). The gene discussed is BRCA2; the disease is pancreatic neoplasm.